730708 |
FRONTIERS IN ONCOLOGY |
Anti-Thymocyte Globulin Prophylaxis in Patients With Hematological Malignancies Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: An Updated Meta-Analysis |
2021-08-20 |
10.3389/fonc.2021.717678 |
Yang Xue, Li Dongjun, Xie Yao |
730707 |
FRONTIERS IN ONCOLOGY |
Effect and Safety of Therapeutic Regimens for Patients With Germline BRCA Mutation-Associated Breast Cancer: A Network Meta-Analysis |
2021-08-20 |
10.3389/fonc.2021.718761 |
Jiang Ying, Meng Xiang-Yu, Deng Ning-Ning, Meng Chen, Li Lu-Hui, He Zi-Kang, Wang Xing-Yun, Song Zhe-Yao, Cui Rong-Jun |
730706 |
FRONTIERS IN ONCOLOGY |
Machine Learning-Based Analysis of Magnetic Resonance Radiomics for the Classification of Gliosarcoma and Glioblastoma |
2021-08-20 |
10.3389/fonc.2021.699789 |
Qian Zenghui, Zhang Lingling, Hu Jie, Chen Shuguang, Chen Hongyan, Shen Huicong, Zheng Fei, Zang Yuying, Chen Xuzhu |
730705 |
FRONTIERS IN ONCOLOGY |
Comprehensive Pan-Cancer Analysis and the Regulatory Mechanism of ASF1B, a Gene Associated With Thyroid Cancer Prognosis in the Tumor Micro-Environment |
2021-08-20 |
10.3389/fonc.2021.711756 |
Ma Jing, Han Wei, Lu Kai |
730704 |
FRONTIERS IN ONCOLOGY |
Prognostic Role of Programmed Death Ligand-1 on Tumor-Infiltrating Immune Cells in “High-Risk” Patients Following Radical Cystectomy: A Retrospective Cohort Study |
2021-08-20 |
10.3389/fonc.2021.706503 |
Lee Chung Un, Lee Dong Hyeon, Song Wan |
730703 |
FRONTIERS IN ONCOLOGY |
Caveolin-1, a Key Mediator Across Multiple Pathways in Glioblastoma and an Independent Negative Biomarker of Patient Survival |
2021-08-20 |
10.3389/fonc.2021.701933 |
Moriconi Chiara, Civita Prospero, Neto Catia, Pilkington Geoffrey J., Gumbleton Mark |
730702 |
FRONTIERS IN ONCOLOGY |
Stem Cells in Myelodysplastic Syndromes and Acute Myeloid Leukemia: First Cousins or Unrelated Entities? |
2021-08-20 |
10.3389/fonc.2021.730899 |
Joudinaud Romane, Boyer Thomas |
730701 |
FRONTIERS IN ONCOLOGY |
Are People With Blood Group O More Susceptible to Nasopharyngeal Carcinoma and Have Worse Survival Rates? A Systematic Review and Meta-Analysis |
2021-08-20 |
10.3389/fonc.2021.698113 |
Jing Shao-wu, Xu Qing, Zhang Xin-yuan, Jing Zhong-hao, Zhao Zhi-jun, Zhang Ruo-hui, Wu Feng-peng, Wang Jun |
730700 |
FRONTIERS IN ONCOLOGY |
The Combined Treatment With the FLT3-Inhibitor AC220 and the Complex I Inhibitor IACS-010759 Synergistically Depletes Wt- and FLT3-Mutated Acute Myeloid Leukemia Cells |
2021-08-20 |
10.3389/fonc.2021.686765 |
Lu Xiyuan, Han Lina, Busquets Jonathan, Collins Meghan, Lodi Alessia, Marszalek Joseph R., Konopleva Marina, Tiziani Stefano |
730699 |
FRONTIERS IN ONCOLOGY |
Identification of Eleven Novel BRCA Mutations in Tunisia: Impact on the Clinical Management of BRCA Related Cancers |
2021-08-20 |
10.3389/fonc.2021.674965 |
Hamdi Yosr, Mighri Najah, Boujemaa Maroua, Mejri Nesrine, Ben Nasr Sonia, Ben Rekaya Mariem, Messaoud Olfa, Bouaziz Hanen, Berrazega Yosra, Rachdi Haifa, Jaidane Olfa, Daoud Nouha, Zribi Aref, Ayari Jihene, El Benna Houda, Labidi Soumaya, Ben Hassouna Jamel, Haddaoui Abderazzek, Rahal Khaled, Benna Farouk, Mrad Ridha, Ben Ahmed Slim, Boussen Hamouda, Boubaker Samir, Abdelhak Sonia |